NPPB and atrial fibrillation: Moreover, the study demonstrated a favourable NT-proBNP response in a subgroup of patients without atrial fibrillation, which was comparable with that in the previous studies in the acute and chronic settings of HF.25,26 These findings may affect future guidelines for the use of Sac/Val and its combination with other GDMTs in the clinical setting of AHF.